Novel Platforms for Systematic Optical Control of Complex Neural Circuits In Vivo A key feature of neural circuits in the mammalian brain is their 3-dimensionality and geometric complexity. In order to understand how normal and pathological brain functions emerge from these complex circuits, we propose to discover new reagents and invent new devices capable of perturbing activity in these structures, in their true 3-D complexity, thus enabling us to understand the causal contribution of each of these circuits to neurological and psychiatric disorders, and to powerful functions of the brain such as sensation, emotion, cognition, and action. Using molecular sensitizers that we have developed, such as channelrhodopsin-2 and halorhodopsin, as well as new molecules that we plan to develop for powerful neural silencing of circuits (Aim 1), we can use light to turn neurons on and off, enabling rapid assessment of their function in intact circuits. However, to date it has not been possible to manipulate neural circuits in their 3-D complexity, in the intact brain. We will develop micromachined, custom-fabricatable structures and technologies capable of delivering light to arbitrary structures in the brain (Aims 2 and 3), thus enabling real- time parsing of how complexly-shaped neural circuits operate in the normal and abnormal brain. Our inventions may directly enable new therapies, by subserving a new generation of optical prosthetics capable of using light to treat neurological and psychiatric disorders.

Public Health Relevance

The ability to parse out how complex, 3-D neural circuits - such as the curved hippocampus, or the distributed frontoamygdala projection - causally contribute to normal and pathological brain functions is essential for the understanding of how mental disorders such as drug addiction arise from corrupted neural circuits in the brain. Our proposal will yield the first reagents and devices capable of activating and silencing these structures in their true 3-D complexity, alone and in combination, thus enabling new understandings of how different brain structures and neural circuits, of complex anatomical circuit complexity, contribute to normal and aberrant brain function. In addition, our inventions may directly enable new therapies for improving human health, through translational work. 1

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA029639-04
Application #
8492051
Study Section
Neurotechnology Study Section (NT)
Program Officer
Pilotte, Nancy S
Project Start
2010-07-01
Project End
2014-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
4
Fiscal Year
2013
Total Cost
$443,427
Indirect Cost
$164,922
Name
Massachusetts Institute of Technology
Department
Miscellaneous
Type
Other Domestic Higher Education
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Schmidt, Daniel; Tillberg, Paul W; Chen, Fei et al. (2014) A fully genetically encoded protein architecture for optical control of peptide ligand concentration. Nat Commun 5:3019
Chuong, Amy S; Miri, Mitra L; Busskamp, Volker et al. (2014) Noninvasive optical inhibition with a red-shifted microbial rhodopsin. Nat Neurosci 17:1123-9
Klapoetke, Nathan C; Murata, Yasunobu; Kim, Sung Soo et al. (2014) Independent optical excitation of distinct neural populations. Nat Methods 11:338-46
Glaser, Joshua I; Zamft, Bradley M; Marblestone, Adam H et al. (2013) Statistical analysis of molecular signal recording. PLoS Comput Biol 9:e1003145
Chow, Brian Y; Han, Xue; Boyden, Edward S (2012) Genetically encoded molecular tools for light-driven silencing of targeted neurons. Prog Brain Res 196:49-61
Borgers, Christoph; Talei Franzesi, Giovanni; Lebeau, Fiona E N et al. (2012) Minimal size of cell assemblies coordinated by gamma oscillations. PLoS Comput Biol 8:e1002362
Bernstein, Jacob G; Garrity, Paul A; Boyden, Edward S (2012) Optogenetics and thermogenetics: technologies for controlling the activity of targeted cells within intact neural circuits. Curr Opin Neurobiol 22:61-71
Chow, Brian Y; Chuong, Amy S; Klapoetke, Nathan C et al. (2011) Synthetic physiology strategies for adapting tools from nature for genetically targeted control of fast biological processes. Methods Enzymol 497:425-43
Wentz, Christian T; Bernstein, Jacob G; Monahan, Patrick et al. (2011) A wirelessly powered and controlled device for optical neural control of freely-behaving animals. J Neural Eng 8:046021
Bernstein, Jacob G; Boyden, Edward S (2011) Optogenetic tools for analyzing the neural circuits of behavior. Trends Cogn Sci 15:592-600

Showing the most recent 10 out of 11 publications